Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis

Sponsor
Case Western Reserve University (Other)
Overall Status
Completed
CT.gov ID
NCT01572714
Collaborator
National Multiple Sclerosis Society (Other)
208
1
3
67.1
3.1

Study Details

Study Description

Brief Summary

The objective of this study is to conduct a randomized controlled trial to examine the effectiveness of a telehealth intervention that supports individuals in managing fatigue and increasing physical activity (PA) behavior in individuals with multiple sclerosis (MS). The hypothesis is that a fatigue management plus physical activity intervention will significantly improve fatigue, quality of life, physical function, and community integration.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Social Support Program
  • Behavioral: Physical Activity Program
  • Behavioral: Physical Activity Plus Fatigue Management Education Program
N/A

Detailed Description

The long-term objective of this study is to use a telehealth intervention approach to reduce the devastating effects of the reciprocal relationship between fatigue and inactivity on quality of life and participation in life roles in people with multiple sclerosis (MS). Chronic fatigue and inactivity are common problems in persons with MS, and the reciprocal relationship between fatigue and inactivity may have negative synergistic effects on quality of life and participation in life roles. The proposed study is novel in that it represents a multi-disciplinary effort to merge two promising lines of MS research: fatigue management and PA promotion. The proposed fatigue management plus PA intervention (FM+) will consist of incorporating a modified teleconference version of Packer et al.'s empirically-tested Fatigue Management program with innovative, yet simple approaches to promote lifestyle PA by encouraging goal-setting and self-monitoring with a pedometer. Ambulatory individuals with MS will be recruited and randomized into one of three telehealth interventions: social support intervention, PA-only intervention, and FM+.

Study Design

Study Type:
Interventional
Actual Enrollment :
208 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Examining the Effects of Physical Activity Promotion, Fatigue Management Education, and Social Support Using a Telehealth Intervention Approach Among Adults With Multiple Sclerosis
Study Start Date :
Jul 1, 2011
Actual Primary Completion Date :
Feb 1, 2017
Actual Study Completion Date :
Feb 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Social Support Program

The social support program will consist of 6 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Topics will include information on MS, disease modifying medications, preventive screening, community organizations, nutrition, cognitive problems, and hiring an aide.

Behavioral: Social Support Program
The social support program will consist of 6 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Topics will include information on MS, disease modifying medications, preventive screening, community organizations, nutrition, cognitive problems, and hiring an aide.
Other Names:
  • Social support
  • Active Comparator: Physical Activity Program

    The physical activity education program will consist of 3 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Subjects in this program will learn MS-specific benefits of physical activity, how to use a pedometer to self-monitor their progress for increasing physical activity levels, and learn strategies for maintaining their progress in the program.

    Behavioral: Physical Activity Program
    The physical activity education program will consist of 3 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Subjects in this program will learn MS-specific benefits of physical activity, how to use a pedometer to self-monitor their progress for increasing physical activity levels, and learn strategies for maintaining their progress in the program.
    Other Names:
  • Physical Activity-only
  • Active Comparator: Physical Activity Plus Fatigue

    The physical activity plus fatigue management education program will consist of 6 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Subjects in this program will learn MS-specific benefits of physical activity, how to use a pedometer to self-monitor their progress for increasing physical activity levels, and learn strategies for maintaining their progress in the program. In addition, subjects in this course will learn strategies to reduce fatigue, such as taking rest breaks and re-arranging workspace.

    Behavioral: Physical Activity Plus Fatigue Management Education Program
    The physical activity plus fatigue management education program will consist of 6 weekly, 1.25-hours, teleconference calls with 4 biweekly, 15 minute, follow-up one-to-one phone calls. Subjects in this program will learn MS-specific benefits of physical activity, how to use a pedometer to self-monitor their progress for increasing physical activity levels, and learn strategies for maintaining their progress in the program. In addition, subjects in this course will learn strategies to reduce fatigue, such as taking rest breaks and re-arranging workspace.
    Other Names:
  • Physical Activity +
  • Outcome Measures

    Primary Outcome Measures

    1. Changes from baseline in physical activity levels [Each patient will be given the assessments at 3 points during the study, at baseline, interim test (an average of 12 weeks from baseline) and at posttest (an average of 24 weeks from baseline).]

      Physical activity behavior will be measured with the Godin Leisure-Time Exercise Questionnaire and accelerometers.

    Secondary Outcome Measures

    1. Changes from baseline in fatigue levels [Each patient will be given the questionnaire at 3 points during the study, at baseline, interim test (an average of 12 weeks from baseline) and at posttest (an average of 24 weeks from baseline).]

      Fatigue will be measured with the Fatigue Impact Scale.

    2. Changes from baseline in quality of life [Each patient will be given the questionnaires at 3 points during the study, at baseline, interim test (an average of 12 weeks from baseline) and at posttest (an average of 24 weeks from baseline).]

      The SF-12, Multiple Sclerosis Impact Scale, and Community Participation Indicator (CPI) will be administered.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • A physician-confirmed diagnosis of MS
    Exclusion Criteria:
    • Exercise more than 90 minutes per week

    • Pregnant

    • Metabolic or cardiopulmonary disease that puts patient at high risk for engaging in a home exercise program (patients with controlled diabetes and high blood pressure will still be considered eligible)

    • Four or more falls in the past 6 months

    • Be able to walk 25 feet with or without a cane or walker

    • Severe cognitive deficits

    • A condition besides MS that had lead to hospitalization in the past year

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Case Western Reserve University Cleveland Ohio United States 44106

    Sponsors and Collaborators

    • Case Western Reserve University
    • National Multiple Sclerosis Society

    Investigators

    • Principal Investigator: Matthew A Plow, PhD, Case Western Reserve University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Matthew Plow, Project Scientist, Case Western Reserve University
    ClinicalTrials.gov Identifier:
    NCT01572714
    Other Study ID Numbers:
    • 03-14-19
    First Posted:
    Apr 6, 2012
    Last Update Posted:
    Jan 6, 2022
    Last Verified:
    Dec 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Matthew Plow, Project Scientist, Case Western Reserve University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 6, 2022